Celldex Therapeutics, Inc. Proceeds from Long-Term Debt Issued
Celldex Therapeutics, Inc. (CLDX) reported Proceeds from Long-Term Debt Issued of -$11.03 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2014-03-03
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2013-06-30 was -$9.71M.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2013-03-31 was -$1.32M.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2012-12-31 was -$1.32M.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for the quarter ending 2012-09-30 was -$1.32M.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2013 was -$11.03M.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2012 was -$3.97M, a 179.42% decline from fiscal 2011.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2011 was $5.00M, a 50.00% decline from fiscal 2010.
- Celldex Therapeutics, Inc. proceeds from issuance of long-term debt for fiscal 2010 was $10.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | -$11.03M 10-K · filed 2014-03-03 | |||
| 2013-06-30 | -$9.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$11.03M 10-Q · filed 2013-08-06 | -$12.35M derived: sum of 3 quarters · filed 2014-03-03 | -$13.68M derived: sum of 4 quarters · filed 2014-03-03 |
| 2013-03-31 | -$1.32M 10-Q · filed 2013-05-03 | -$2.65M derived: sum of 2 quarters · filed 2014-03-03 | -$3.97M derived: sum of 3 quarters · filed 2014-03-03 | |
| 2012-12-31 | -$1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$2.65M derived: sum of 2 quarters · filed 2014-03-03 | -$3.97M 10-K · filed 2014-03-03 | |
| 2012-09-30 | -$1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$2.65M 10-Q · filed 2012-11-02 | ||
| 2012-06-30 | -$1.32M 10-Q · filed 2013-08-06 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $0.00 derived: sum of 2 quarters · filed 2014-03-03 | $0.00 derived: sum of 3 quarters · filed 2014-03-03 | $5.00M 10-K · filed 2014-03-03 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $0.00 derived: sum of 2 quarters · filed 2012-11-02 | $5.00M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $5.00M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $5.00M 10-Q · filed 2012-05-04 | |||
| 2010-12-31 | $10.00M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |